India has approved two COVID-19 vaccines – Covishield ‘from the Serum Institute of India and’ Covaxin ‘from Bharat Biotech – for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines should be given in two doses and should be stored at 2-8 ° C. Also read: Why people …
Read More »
One day after Samajwadi Party chief Akhilesh Yadav questioned India’s Covid-19 vaccines and said he would not take “the BJP vaccine,” Congressional leaders Jairam Ramesh, Shashi Tharoor also doubted approval. awarded to the Bharat Biotech vaccine while in its third phase of testing. . Criticizing their doubts, Union Minister Hardeep …
Read More »
After the Controller General of Drugs of India (DCGI) gave the green signal on Sunday to two candidate vaccines for restricted and emergency use, Union Minister Rajnath Singh praised Prime Minister Narendra Modi’s vision for Aatmanirbhar Bharat, who said that he has greatly helped India to come. with indigenous solutions …
Read More »
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
Covaxin is being developed by Hyderabad-based Bharat Biotech. New Delhi: Covaxin, India’s first indigenous vaccine for the highly infectious coronavirus, has been designed to be effective if a person takes two doses, Hyderabad-based pharmaceutical company Bharat Biotech clarified in a statement today, noting that “efficacy can be determine 14 days …
Read More »